Anca Milea

Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

Stephen M. Ansell, Michael B. Maris, Alexander M. Lesokhin et al. · Clinical Cancer Research · 2021 · 183 citations · Full text

A distinct innate lymphoid cell population regulates tumor-associated T cells

Sarah Q. Crome, Linh T. Nguyen, Sandra López‐Vergès et al. · Nature Medicine · 2017 · 139 citations · Full text

Cancer Immunosurveillance, Autoimmune Disease, Lymphocyte Development +11

Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary

Taymaa May, Carl Virtanen, Monika Sharma et al. · Gynecologic Oncology · 2010 · 69 citations

Tumoral Pathology, Endocrine-related Cancer, Medicine +8

Retinoblastoma pathway deregulatory mechanisms determine clinical outcome in high-grade serous ovarian carcinoma

Anca Milea, Sophia George, Donco Matevski et al. · Modern Pathology · 2013 · 52 citations

Medicine, Gynecology, Pathology +8

Proliferation in the Normal FTE Is a Hallmark of the Follicular Phase, Not BRCA Mutation Status

Sophia George, Anca Milea, Patricia A. Shaw · Clinical Cancer Research · 2012 · 40 citations